
Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response
Author(s) -
Gerd Bodlaj,
Rainer Hubmann,
Karim Saleh,
Tatjana Stojaković,
Georg Biesenbach,
J. V. R. Berg
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i19.2407
Subject(s) - ribavirin , medicine , gastroenterology , pegylated interferon , hepatitis c virus , alkaline phosphatase , hepatitis c , immunology , biology , virus , enzyme , biochemistry
To investigate relapse predictors in chronic hepatitis C (CHC) patients with end-of-treatment response (ETR), after pegylated interferon-alpha (PegIFN-alpha) and ribavirin treatment.